Literature DB >> 7556320

Mother-to-child transmission of human immunodeficiency virus type 1: influence of parity and mode of delivery. Paediatric AIDS Group of Switzerland.

C Kind1.   

Abstract

UNLABELLED: In a national prospective study of risk factors for mother-to-child transmission of human immunodeficiency virus (HIV), 316 children of HIV-positive mothers were followed up for at least 6 months. Infection status was determined in 254 of them and 46 were found to be infected giving a transmission rate of 18.1%. Univariate analysis of potential risk factors for mother-to-child transmission showed an association between primiparity and increased transmission rate: odds ratio 2.2, 95% confidence interval (CI) 1.1-4.6, P < 0.05. Analysis by logistic regression confirmed this association (adjusted odds ratio 2.4) and showed, in addition, a negative association between transmission rate and elective Caesarean section (adjusted odds ratio 0.36, 95% CI 0.13-0.97, P < 0.05). The effect of primiparity was less pronounced in combination with elective Caesarean section (odds ratio 1.7) than with other delivery modes (odds ratio 2.5, difference not significant). HIV-infected children were less likely to experience the birth of a younger sibling during the observation period than their uninfected counterparts (2 of 46 vs 27 of 208, P < 0.05 by logrank test).
CONCLUSION: Primiparous women appear to transmit HIV to their children at a higher rate. This could be explained by increased intrapartum transmission because of longer and more complicated labour in primiparas and/or by a self-selection of women with lower risk of transmission among those deciding to have additional children.

Entities:  

Mesh:

Year:  1995        PMID: 7556320     DOI: 10.1007/bf02074831

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  9 in total

1.  Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1986-05-23       Impact factor: 17.586

Review 2.  Risk factors for vertical transmission of HIV-1 and early markers of HIV-1 infection in children.

Authors:  M L Newell; C Peckham
Journal:  AIDS       Date:  1993       Impact factor: 4.177

3.  Mode of delivery and vertical transmission of HIV-1: a review of prospective studies. Perinatal AIDS Collaborative Transmission Studies.

Authors:  D T Dunn; M L Newell; M J Mayaux; C Kind; C Hutto; J J Goedert; W Andiman
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1994-10

4.  [Growing-up of children from HIV-positive mothers in Switzerland. Pediatric AIDS-Group Switzerland].

Authors:  M Künzel; C Kind
Journal:  Schweiz Med Wochenschr       Date:  1992-04-04

5.  Epidemiology of vertically transmitted HIV-1 infection in Switzerland: results of a nationwide prospective study. Swiss Neonatal HIV Study Group.

Authors:  C Kind; B Brändle; C A Wyler; A Calame; C Rudin; U B Schaad; J Schüpbach; H P Senn; L Perrin; L Matter
Journal:  Eur J Pediatr       Date:  1992-06       Impact factor: 3.183

6.  Sensitive detection and early prognostic significance of p24 antigen in heat-denatured plasma of human immunodeficiency virus type 1-infected infants. Swiss Neonatal HIV Study Group.

Authors:  J Schüpbach; J Böni; Z Tomasik; J Jendis; R Seger; C Kind
Journal:  J Infect Dis       Date:  1994-08       Impact factor: 5.226

7.  Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors:  E M Connor; R S Sperling; R Gelber; P Kiselev; G Scott; M J O'Sullivan; R VanDyke; M Bey; W Shearer; R L Jacobson
Journal:  N Engl J Med       Date:  1994-11-03       Impact factor: 91.245

8.  Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1994-08-05

9.  Caesarean section and risk of vertical transmission of HIV-1 infection. The European Collaborative Study.

Authors: 
Journal:  Lancet       Date:  1994-06-11       Impact factor: 79.321

  9 in total
  6 in total

1.  Working group consultation: alloimmunity as a vaccine approach against HIV/AIDS: National Institutes of Health Meeting Report, May 24, 2012.

Authors:  Anjali Singh; Jon Warren; Alan Schultz; Charles J Hackett; Opendra Sharma
Journal:  AIDS Res Hum Retroviruses       Date:  2013-04-23       Impact factor: 2.205

Review 2.  Mother-to-child transmission of human immunodeficiency virus type 1.

Authors:  G C John; J Kreiss
Journal:  Epidemiol Rev       Date:  1996       Impact factor: 6.222

3.  Cost-effectiveness of Childbirth Strategies for Prevention of Mother-to-child Transmission of HIV Among Mothers Receiving Nevirapine in India.

Authors:  Kanchan Mukherjee
Journal:  Indian J Community Med       Date:  2010-01

4.  Suppressed cellular alloimmune responses in HIV-exposed seronegative female sex workers.

Authors:  W Jennes; D Evertse; M-Y Borget; B Vuylsteke; C Maurice; J N Nkengasong; L Kestens
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

Review 5.  Elective cesarean section for women living with HIV: a systematic review of risks and benefits.

Authors:  Caitlin E Kennedy; Ping T Yeh; Shristi Pandey; Ana P Betran; Manjulaa Narasimhan
Journal:  AIDS       Date:  2017-07-17       Impact factor: 4.177

6.  Heterosexual and homosexual partners practising unprotected sex may develop allogeneic immunity and to a lesser extent tolerance.

Authors:  Cherry Kingsley; Barry Peters; Kaboutar Babaahmady; Laura Pomeroy; Durdana Rahman; Robert Vaughan; Thomas Lehner
Journal:  PLoS One       Date:  2009-11-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.